Literature DB >> 16648049

Aplastic anaemia in patient with glioblastoma multiforme treated with temozolomide.

J Lee Villano1, Cindy A Collins, Elisabet E Manasanch, Charulata Ramaprasad, Koen van Besien.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16648049     DOI： 10.1016/S1470-2045(06)70696-9

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  17 in total

1.  Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma.

Authors:  Christina I Tsien; Doris Brown; Daniel Normolle; Matthew Schipper; Morand Piert; Larry Junck; Jason Heth; Diana Gomez-Hassan; Randall K Ten Haken; Thomas Chenevert; Yue Cao; Theodore Lawrence
Journal:  Clin Cancer Res       Date:  2011-11-07       Impact factor: 12.531

2.  Aplastic anemia as a cause of death in a patient with glioblastoma multiforme treated with temozolomide.

Authors:  Jindrich Kopecký; Peter Priester; Ladislav Slovácek; Jirí Petera; Otakar Kopecký; Zuzana Macingova
Journal:  Strahlenther Onkol       Date:  2010-07-29       Impact factor: 3.621

3.  Aplastic anemia with concurrent temozolomide treatment in a patient with glioblastoma multiforme.

Authors:  J Oh; G J Kutas; P Davey; M Morrison; J R Perry
Journal:  Curr Oncol       Date:  2010-08       Impact factor: 3.677

4.  Bone marrow transplantation for severe aplastic anemia secondary to temozolomide.

Authors:  E Brannon Morris; Kimberly Kasow; Ulrike Reiss; David Ellison; Alberto Broniscer
Journal:  J Neurooncol       Date:  2008-09-26       Impact factor: 4.130

5.  Temozolomide-induced myelodysplasia.

Authors:  Ethan A Natelson; David Pyatt
Journal:  Adv Hematol       Date:  2010-03-04

6.  Persistent bone marrow depression following short-term treatment with temozolomide.

Authors:  Kathrine Vandraas; Geir Erland Tjønnfjord; Tom Børge Johannesen; Petter Brandal
Journal:  BMJ Case Rep       Date:  2016-04-29

7.  Prolonged and severe thrombocytopenia with pancytopenia induced by radiation-combined temozolomide therapy in a patient with newly diagnosed glioblastoma--analysis of O6-methylguanine-DNA methyltransferase status.

Authors:  Motoo Nagane; Kyoko Nozue; Saki Shimizu; Andreas Waha; Hiroshi Miyazaki; Hiroki Kurita; Masashi Homori; Yasunori Fujioka; Yoshiaki Shiokawa
Journal:  J Neurooncol       Date:  2008-11-27       Impact factor: 4.130

Review 8.  Prolonged and severe myelosuppression in two patients after low-dose temozolomide treatment- case study and review of literature.

Authors:  Nimit Singhal; Sudarshan Selva-Nayagam; Michael P Brown
Journal:  J Neurooncol       Date:  2007-05-26       Impact factor: 4.130

9.  Tuberculosis in a patient on temozolomide: a case report.

Authors:  Tadeu Ferreira de Paiva; Milton José de Barros e Silva; José Augusto Rinck; Marcello Ferreti Fanelli; Daniel Luiz Gimenes
Journal:  J Neurooncol       Date:  2008-11-01       Impact factor: 4.130

10.  Unexpected case of aplastic anemia in a patient with glioblastoma multiforme treated with Temozolomide.

Authors:  Rakesh Jalali; Pritanjali Singh; Hari Menon; Sumeet Gujral
Journal:  J Neurooncol       Date:  2007-05-16       Impact factor: 4.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.